You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced stage

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Sep 19, 2023

Cancer, Palliative Care Trial (Yunzhi Essence, Placebo)

Not yet recruiting
  • Cancer
  • Palliative Care
  • Yunzhi Essence
  • Placebo
  • (no location specified)
Mar 7, 2023

Fibrolamellar Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, DRP-104)

Not yet recruiting
  • Fibrolamellar Hepatocellular Carcinoma
  • Baltimore, Maryland
    Johns Hopkins SKCCC
Aug 30, 2023

Lung Cancer Trial (Weekly symptom monitoring)

Not yet recruiting
  • Lung Cancer
  • Weekly symptom monitoring
  • (no location specified)
Nov 11, 2022

Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Fungoides Mycosis Sezary Syndrome
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Jul 13, 2023

NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Jun 26, 2023

Hepatocellular Carcinoma Trial in Shanghai (Anti-PD-1/PD-L1, S-Adenosyl-Methionine)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Zhongshan Hospital Fudan university
Jan 31, 2023

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Cancer Trial in Tampa (Six Week Physical Activity Intervention, Progress Reporting)

Completed
  • Cancer
  • Six Week Physical Activity Intervention
  • Progress Reporting
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2022

CYP3A Inhibitor, Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma Trial in Heidelberg (Cobicistat Oral Tablet)

Not yet recruiting
  • CYP3A Inhibitor
  • Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
  • Cobicistat Oral Tablet
  • Heidelberg, BW, Germany
    University Hospital Heidelberg
Aug 10, 2022

Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • carboplatin chemotherapy
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Nov 3, 2023

Colorectal Cancer Trial in Durham (VR Blue)

Completed
Has Results
  • Colorectal Cancer
  • VR Blue
  • Durham, North Carolina
    Duke Cancer Institute
Jul 27, 2022

NSCLC Trial in Celebration, Detroit, Durham (GT103)

Recruiting
  • Non-small Cell Lung Cancer
  • Celebration, Florida
  • +2 more
Nov 22, 2022

Colorectal Tumors Malignant Trial in Beijing (Fecal microbiota transplantation plus Sintilimab and Fruquintinib)

Recruiting
  • Colorectal Neoplasms Malignant
  • Fecal microbiota transplantation plus Sintilimab and Fruquintinib
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Aug 21, 2022

Anorexia Nervosa With Significantly Low Body Weight Trial in Englewood (Mirtazapine, Olanzapine)

Enrolling by invitation
  • Anorexia Nervosa With Significantly Low Body Weight
  • Englewood, New Jersey
    Englewood Health
Jul 25, 2022

dMMR Colorectal Cancer Trial in Beijing (Cadonilimab)

Recruiting
  • dMMR Colorectal Cancer
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Apr 13, 2023

Anxiety Trial in Torrance (Psilocybin (drug), Active Niacin Placebo)

Completed
  • Anxiety
  • Psilocybin (drug)
  • Active Niacin Placebo
  • Torrance, California
    Harbor-UCLA Medical Center
Apr 14, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Sin-Bev-TACE, Len-TACE)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Aug 2, 2023

Tumors Trial in Israel, Spain (JNJ-78306358)

Recruiting
  • Neoplasms
  • Haifa, Israel
  • +4 more
Aug 11, 2022

Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

Not yet recruiting
  • Ovarian Cancer
  • Carboplatin AUC 5 and paclitaxel
  • Bintrafusp alfa (M7824)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jul 12, 2022

Advanced Hepatocellular Carcinoma Trial in Hannover (Lenvatinib, Nivolumab)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma
  • Hannover, Germany
    Hannover Medical School
Mar 30, 2022

NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Stage IV
  • Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
  • +2 more
  • Aarau, Switzerland
  • +7 more
Oct 27, 2023

HER2-positive Breast Cancer Trial in Nanjing (Pyrotinib)

Recruiting
  • HER2-positive Breast Cancer
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 26, 2023

Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous

Active, not recruiting
  • Epidermotropic T-cell Lymphomas
  • HSCT
  • Standard Care
  • Paris, France
    Saint Louis hospital
Apr 15, 2022

Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
  • TACE
  • Nanjing, China
  • +1 more
Dec 28, 2022